Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5103243

Cc1ccc(-c2ccc(C)cc2NC(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
IDH2 P48735 1/20 0.43
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
APP P05067 1/20 0.38
MAPT P10636 4/20 0.37
HDAC7 Q8WUI4 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5113759 0.93 KCNMA1 (0.45) AKR1C3AKR1C2IDH2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5103755 0.90 FFAR4 (0.44) AKR1C3AKR1C2IDH2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5113233 0.89 FABP4 (0.46) AKR1C3AKR1C2IDH2PDK1PDK2
Trifluoroacetic Acid SCHEMBL5099217 0.88 AKR1C3 (0.41) AKR1C3AKR1C2IDH2PDK1PDK2
Trifluoroacetic Acid SCHEMBL5099269 0.87 AKR1C3 (0.44) AKR1C3AKR1C2IDH2PDK2NPC1
Trifluoroacetic Acid SCHEMBL5099983 0.86 RAB9A (0.39) AKR1C3AKR1C2IDH2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5103685 0.84 MEN1 (0.44) IDH2PDK1PDK2PDK3PDK4
Trifluoroacetic Acid SCHEMBL5113229 0.84 IDH2 (0.44) AKR1C3AKR1C2IDH2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL5107023 0.83 IDH2 (0.45) IDH2PDK1PDK2PDK3PDK4
SCHEMBL3906980 0.82 HDAC7 (0.53) NPC1RAB9AMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 AKR1C3 1908/4885AKR1C2 2538/4885IDH2 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.